Brief: Jhbp Cy - Entered Into Cooperative Development Agreement With Suzhou Abogen Biosciences
24/06/2022 15:24
Genor Biopharma Holdings Ltd 6998.HK :
* JHBP CY - ENTERED INTO COOPERATIVE DEVELOPMENT AGREEMENT
WITH
SUZHOU ABOGEN BIOSCIENCES
* JHBP CY - DEAL TO JOINTLY DEVELOP GLOBALLY INNOVATIVE MRNA
PRODUCTS AND RELATED PHARMACEUTICALS
Source text for Eikon: ID:nHKScHxxb
Further company coverage: 6998.HK
Recent news on Edding Genor group
See all newsBrief: JHBP CY Says Chairman And CEO Ni Xin To Buy Shares Up To USD 1 Million From Aug 31, 2026
Brief: Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HY
Brief: Jhbp Cy Disposal Of Equity Interest In Candid Therapeutics
Edding Genor climbs on approval of clinical trial of cancer drug in China
Brief: JHBP CY's Phase Ib/Ii Clinical Trial Of Gb268 Obtains IND Approval By NMPA